Extrapulmonary Tuberculosis
Cross-source consensus on Extrapulmonary Tuberculosis from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Highlighted claims
- Delayed or missed diagnosis of EPTB in low-resource settings can increase morbidity, mortality, hospital costs, productivity losses, and health-system strain. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- Extrapulmonary tuberculosis poses clinical and economic challenges because diagnosis is often complex and may require invasive sampling. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- HIV endemicity in Sub-Saharan Africa increases EPTB prevalence and worsens outcomes. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol
- The planned review includes EPTB forms such as pleural, pericardial, peritoneal, and meningeal disease. — Economic evidence of health technology innovations for the diagnosis of extrapulmonary TB in resource-limited settings: a scoping review protocol